Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
AVENUE THERAPEUTICS, INC. (ATXI)
|
Add to portfolio |
|
|
|
| Price: |
$0.93
| | Metrics |
| OS: |
8.18
|
M
| |
-95
|
% ROE
|
| Market cap: |
$7.61
|
M
| |
-2489
|
% ROIC
|
|
Net cash:
|
$12.3
|
M
| |
$1.50
|
per share
|
|
EV:
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($14.9)
|
M
| |
|
|
|
EBIT
|
($14.9)
|
M
| |
|
|
| EPS |
($2.06)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 0.0 | 0.0 | 0.0 | -1.0 | 0.0 | 0.0 | 0.0 |
| Revenue growth | | | -100.0% | | | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | -1.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | | | | 100.0% | | | |
| Research and development | 2.7 | 1.3 | 2.9 | 22.2 | 17.7 | 6.7 | 1.3 |
| General and administrative | 5.3 | 2.5 | 2.3 | 3.1 | 4.1 | 3.6 | 1.0 |
| EBIT | -8.0 | -3.7 | -5.2 | -26.3 | -21.8 | -10.3 | -2.3 |
| EBIT margin | | | | 2626.5% | | | |
| Pre-tax income | -3.6 | -3.7 | -5.2 | -25.9 | -21.5 | -12.3 | -3.2 |
| Income taxes | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 1.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -3.6 | -3.7 | -5.2 | -25.9 | -21.5 | -12.3 | -3.2 |
| Net margin | | | | 2590.8% | | | |
| |
| Diluted EPS | ($1.63) | ($3.29) | ($0.31) | ($1.65) | ($2.10) | ($1.85) | ($1.11) |
| Shares outstanding (diluted) | 2.2 | 1.1 | 16.5 | 15.7 | 10.2 | 6.6 | 2.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|